|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.525 USD | +1.91% |
|
-10.67% | +92.34% |
| Market Cap | 2.34B 2.05B 1.89B 1.74B 3.31B 223B 3.36B 22.54B 8.85B 110B 8.78B 8.59B 378B | P/E 2026 * |
338x | P/E 2027 * | 344x |
|---|---|---|---|---|---|
| Enterprise Value | 2.18B 1.91B 1.76B 1.62B 3.08B 208B 3.13B 21B 8.25B 102B 8.18B 8B 352B | EV / Sales 2026 * |
0.75x | EV / Sales 2027 * | 0.66x |
| Free-Float |
73.35% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Clover Health Investments, Corp.
| 1 day | +1.91% | ||
| 1 week | -10.67% | ||
| Current month | -13.74% | ||
| 1 month | -6.03% | ||
| 3 months | +122.67% | ||
| 6 months | +77.96% | ||
| Current year | +92.34% |
| 1 week | 4.35 |  | 5.2 |
| 1 month | 4.35 | | 5.59 |
| Current year | 1.58 | | 5.59 |
| 1 year | 1.58 | | 5.59 |
| 3 years | 0.61 | | 5.59 |
| 5 years | 0.61 | | 11.13 |
| 10 years | 0.61 | | 28.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
Andrew Toy
CEO | Chief Executive Officer | 47 | 01/01/2023 |
Clay Thornton
DFI | Director of Finance/CFO | 36 | 30/03/2026 |
Shelly Gupta
CTO | Chief Tech/Sci/R&D Officer | - | 07/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Vivek Garipalli
CHM | Chairman | 47 | 01/01/2023 |
Thomas Tran
BRD | Director/Board Member | 69 | 20/08/2024 |
William Robinson
BRD | Director/Board Member | 61 | 25/03/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 08/07 | Sell | Executive/Senior Manager | -2,384 | 0.0006% | ||
| 06/07 | Sell | Executive/Senior Manager | -6,229 | 0.0014% | ||
| 01/07 | Sell | Founder | -313,476 | 0.0727% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.91% | -10.67% | +50.67% | +362.08% | 2.34B | |
| +1.06% | +2.47% | +42.50% | -4.34% | 386B | |
| +1.93% | +3.67% | +24.43% | +1.33% | 90.39B | |
| +3.20% | +7.11% | -0.34% | +11.84% | 77.63B | |
| +4.09% | +3.67% | +79.06% | -4.01% | 47.09B | |
| +1.60% | +3.35% | +122.80% | +7.25% | 33.26B | |
| +2.54% | +4.84% | +9.03% | -17.59% | 12.15B | |
| +1.89% | -18.20% | +49.93% | +287.09% | 4.1B | |
| +3.80% | +2.26% | +34.77% | -19.29% | 2.4B | |
| +2.17% | -2.44% | -35.60% | - | 280M | |
| Average | +2.41% | -2.75% | +37.73% | +69.37% | 65.53B | |
| Weighted average by Cap. | +1.72% | -0.17% | +41.03% | +1.81% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.91B 2.55B 2.35B 2.17B 4.11B 278B 4.18B 28.05B 11.02B 137B 10.93B 10.69B 470B | 3.32B 2.91B 2.68B 2.48B 4.7B 317B 4.78B 32.04B 12.58B 156B 12.48B 12.21B 537B |
| Net income | 6.42M 5.62M 5.18M 4.79M 9.08M 612M 9.23M 61.9M 24.31M 302M 24.11M 23.59M 1.04B | 7.96M 6.96M 6.42M 5.93M 11.25M 759M 11.44M 76.7M 30.12M 374M 29.88M 29.23M 1.29B |
| Net Debt | -160M -140M -129M -119M -226M -15.22B -229M -1.54B -604M -7.5B -599M -586M -25.77B | -151M -132M -122M -113M -214M -14.43B -217M -1.46B -573M -7.11B -568M -556M -24.43B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/07/26 | USD 4.515 | +1.69% | 1,540,780 |
| 10/07/26 | USD 4.440 | -5.13% | 6,009,913 |
| 09/07/26 | USD 4.680 | +0.43% | 4,668,856 |
| 08/07/26 | USD 4.660 | -6.80% | 7,391,325 |
| 07/07/26 | USD 5.000 | -1.19% | 5,713,809 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CLOV Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition